Compare XOS & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XOS | COSM |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5M | 18.9M |
| IPO Year | N/A | 2013 |
| Metric | XOS | COSM |
|---|---|---|
| Price | $2.23 | $0.46 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 61.5K | ★ 1.4M |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $52,246,000.00 | ★ $59,792,819.00 |
| Revenue This Year | N/A | $20.69 |
| Revenue Next Year | $26.76 | $53.10 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.69 |
| 52 Week Low | $1.74 | $0.28 |
| 52 Week High | $9.15 | $1.32 |
| Indicator | XOS | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 45.79 | 41.83 |
| Support Level | $2.24 | $0.44 |
| Resistance Level | $3.10 | $0.50 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 9.36 | 27.36 |
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.